Bladder Cancer News and Research

Latest Bladder Cancer News and Research

Olfactory receptor in human bladder might prove useful for bladder cancer therapy, diagnosis

Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.

29 May 2018

Researchers identify novel target for bladder cancer

Researchers have identified an olfactory receptor in the human bladder that could prove useful in the diagnosis and treatment of bladder cancer.

29 May 2018

Researchers create tool to determine patient's response to immunotherapy drugs

Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients respond to new immune-based treatments.

21 May 2018

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

KARL STORZ Endoscopy-America, Inc., announces the commercial launch of the PDD Blue Light Flexible Video Cystoscopy System for enhanced detection of non-muscle invasive bladder cancer.

18 May 2018

Combination therapies targeting different cell types may be effective at treating colon cancer

Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed.

16 May 2018

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.

16 May 2018

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.

15 May 2018

Study finds way to better treat men with locally advanced prostate cancer

A new study published today has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy.

10 May 2018

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study by SWOG, an international clinical trials network funded by the National Cancer Institute.

9 May 2018

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.

8 May 2018

Trio's pioneering silicone ostomy product wins prestigious Queen's Award for Enterprise

A life changing silicone adhesive that prevents abdominal stomas from leaking and provides a range of benefits for patients and healthcare professionals, has been awarded the prestigious Queen's Award for Enterprise.

25 Apr 2018

Scientists find link between soil metals and cancer mortality

Spanish epidemiologists and geologists have found associations between esophageal cancer and soils where lead is abundant, lung cancer and terrains with increased copper content, brain tumor with areas rich in arsenic, and bladder cancer with high cadmium levels.

20 Apr 2018

Study: Young children should be priority for snail fever treatment

Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.

17 Apr 2018

Oxygen 'nanobubbles' could help enhance cancer therapies and hasten wound healing

A Purdue University-patented technology shows promise in using microscopic bubbles filled with oxygen to help with various medical treatments, including improving cancer therapeutics and helping wounds heal faster.

13 Apr 2018

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.

12 Apr 2018

Scientists create organoids that could help guide bladder cancer treatment

Researchers have created patient-specific bladder cancer organoids that imitate many of the features of real tumors and may therefore be used to study how cancer evolves.

6 Apr 2018

Researchers develop new non-invasive test for early detection of urothelial cancer

Urothelial cancers of the bladder and upper urinary tract are among the most common cancers encountered worldwide. In the United States, urothelial cancers are among the most costly cancers to treat.

31 Mar 2018

New test for urothelial cancers offers less invasive, more accurate detection

A new test for urothelial cancers could detect mutations in DNA that have been identified for those cancers earlier than traditional tests. The earlier detection of urothelial cancer could lead to earlier treatment, and potentially better outcomes for patients.

23 Mar 2018

Exposure to THMs in residential water not linked to increased risk of breast cancer

Exposure to trihalomethanes in residential water is not associated with an increased risk of breast cancer. This is the main conclusion of a new study by the Barcelona Institute for Global Health, a center supported by the "la Caixa" Banking Foundation.

26 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

Bladder Cancer News and Research

Latest Bladder Cancer News and Research

Olfactory receptor in human bladder might prove useful for bladder cancer therapy, diagnosis

Researchers identify novel target for bladder cancer

Researchers create tool to determine patient's response to immunotherapy drugs

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

Combination therapies targeting different cell types may be effective at treating colon cancer

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Study finds way to better treat men with locally advanced prostate cancer

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Trio's pioneering silicone ostomy product wins prestigious Queen's Award for Enterprise

Scientists find link between soil metals and cancer mortality

Study: Young children should be priority for snail fever treatment

Oxygen 'nanobubbles' could help enhance cancer therapies and hasten wound healing

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

Scientists create organoids that could help guide bladder cancer treatment

Researchers develop new non-invasive test for early detection of urothelial cancer

New test for urothelial cancers offers less invasive, more accurate detection

Exposure to THMs in residential water not linked to increased risk of breast cancer

FDA approves first treatment to reduce risk of NSCLC progression

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Bladder Cancer News and Research

Latest Bladder Cancer News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in